PPT-Clinical Controversies: Recent Updates for Medication Use in Chronic Kidney Disease

Tracy AndersonHaag PharmD BCPS Clinical Pharmacy Specialist Hennepin Healthcare and Clinical Assistant Professor University of Minnesota College of Pharmacy Objectives Describe recent changes to medication labeling guidelines and practice patterns for use of controversial medications in patients with chronic kidney disease. Sharondeep. Gill. Overview. Chronic Kidney Disease. History. Examination. Fistula. Cases. Clinical Topics. Summary. CKD. CKD. GFR <60 for >3 months. Renal failure: GFR<15 or need for dialysis/transplant. Kevin Harley, M.D.. Assistant Clinical Professor. Department of Medicine. Division of Nephrology & Hypertension. UC Irvine Medical Center. Objectives. Review Definition of CKD and its classification. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Chronic Kidney Failure Done by : Resources : Objectives : Extra Book Notes Important Golden Notes Differentiate Chronic kidney disease-CKD from Acute Kidney Injury-AKI. Chronic kidney disease CKD is a condition in which the kidneysare damaged or cannot lter blood as well as healthy kidneys for3 months or longerTHE FACTS ABOUT CKD RISK FACT DID YOU KNOW Its shocking b Andrew . Narva. , MD, FASN & . Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Andrew . Narva. , MD, FASN. No financial disclosures/conflicts of interest. Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Shekhar. Sharma. Assistant Professor,. Department . of . Nephrology. AIIMS, . Rishikesh. . Staging. Chronic kidney disease (CKD) encompasses a spectrum of different pathophysiologic processes associated with abnormal kidney function and a progressive decline in glomerular filtration rate (GFR), present for >3 months.. . Renal Pharmacy Beginners Guide lecture 2 . P. rovide an introduction to the management of chronic kidney disease . Key aims of treatment in CKD. Risk factors for CKD . Frequently prescribed medication. Carrie L. Ernst, MD. Associate Professor of Psychiatry, . Icahn School of Medicine at Mount Sinai. Version of March 15, 2019. Learning Objectives. Describe symptoms and staging of kidney disease. Identify common psychiatric disorders in patients with chronic kidney disease and propose several management strategies. In CKD and HD patients dysfunction of . immu. ne . sy. stem . a. lterations. . belonge. to . . involv. ing. . i. nnate. and . a. daptive. . i. mmunity. in T and B lymphocytes (. Reduced . T regulatory cells and memory cells and increased innate cells). . disease A discussion paper for building resilience and sustainability of healthcare systems International Society of Nephrology March 2021 2 About this discussion paper This discussion paper has Dr. Rashmi Jujare , Dr. Rekha Jagadish . Medical and Research Publications Controversies in Periodontics Written by Dr. Rashmi Jujare . (MDS, Periodontics) – Principal , R esearcher, literature se Martha Cannon . BA VetMB DSAM(Fel) RCVS Specialist in Feline Medicine. Oxford Cat Clinic. Definitions. Acute kidney injury (AKI): . sudden damage to an otherwise healthy kidney. +/- loss of function, spectrum from mild to severe. 2017 . Annual Data Report. Volume 1: Chronic Kidney Disease. 2. vol. 1 Figure 4.1 Prevalence of common cardiovascular diseases in patients with or without CKD, 2015 . Data Source: Special analyses, Medicare 5% sample. Abbreviations: AF, atrial fibrillation; AMI, acute myocardial infarction; CAD, coronary artery disease; CKD, chronic kidney disease; CVA/TIA, cerebrovascular accident/transient ischemic attack; CVD, cardiovascular disease; HF, heart failure; PAD, peripheral arterial disease; SCA/VA, sudden cardiac arrest and ventricular arrhythmias; VHD, .